1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Antibacterial Drugs: World Industry and Market Prospects 2016-2026

Antibacterial Drugs: World Industry and Market Prospects 2016-2026

  • March 2016
  • -
  • Visiongain
  • -
  • 300 pages

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
Antibacterial Drugs: World Industry and Market Prospects 2016-2026 – our new study reveals trends, R&D progress, and predicted revenues
Where is the Antibacterial Drugs market heading? Visiongain’s report shows you the potential revenues streams to 2026, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 300 page report provides 124 tables and 97 figures. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibacterial Drugs market.

Forecasts from 2016-2026 and other analyses reveal the commercial prospects
- In addition to revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares.
- You find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including SWOT and STEP analysis), product profiles and commercial developments.
- Read full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including:
- Dr. Holger Zimmermann, Chief Executive Officer (CEO) of AiCuris Anti-infective Cures GmbH
- Discusses the dynamic of the antibacterial drugs market and the company’s drug candidate, AIC499 for the treatment of Gram-negative infections.
- Dr Bruce R. Donald (Duke University) Dr Amy C. Anderson (University of Connecticut), Mr. Pablo Gainza-Cirauqui (Duke University)
- Discusses OSPREY, the protein-design algorithm to predict mutation.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you find revenue forecasts to 2026 for the following submarkets:
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Other antibiotics.

Our investigation discusses what stimulates and restrains business. Understand the dynamics of the industry and assess its potential future sales, discovering the critical factors likely to achieve success.

Predictions of leading products’ sales – what’s possible for those antibacterial drugs?
How will individual antibacterial drugs perform from 2016 to 2026 at world level? Our study forecasts revenues of these brands:
- Cephalosporins
- Rocephin
- Sulperazon
- Ceftin/Zinnat
- Meiact
- Flomox
- Teflaro
- Zeftera
- Ceftolozane-tazobactam
- Ceftazidime-Avibactam
- Penicillins
- Generic amoxicillin
- Augmentin
- Zosyn/Tazocin
- Unasyn
- Generic amoxicllin-clavulanic acid
- Amoxil

- Fluoroquinolones
- Avelox
- Cravit
- Vigamox
- Ciprodex
- Cipro/Cirpobay
- Geninax
- Defafloxacin

- Macrolides
- Biaxin/Clarith
- Zithromax
- Dalacin
- Dificid
- Solithromycin

- Carbapenems
- Invanz
- Merrem/Meropen
- Primaxin
- Doribax

- Other antibiotics
- Zyvox
- Cubicin
- Tygacil
- TOBI/TIP
- Solodyn
- Vibativ
- Sirturo
- Tedizolid
- Oritavancin
- Dalbavancin
- Nemonoxacin
- Surotomycin

Our analysis also divides the main global forecast into geographical markets.

What are the prospects in the leading regions and countries?
You will discover individual revenue forecasts for 12 leading national markets from 2016-2026:
- United States (US)
- Japan
- Germany, France, the UK, Italy and Spain (EU5 group)
- Brazil, Russia, India and China (BRIC countries).
- South Korea

This chapter also provides incidence of infection and antibacterial drug consumption by country.

Leading companies and the potential for market growth
Our analyses forecasts the world market for antibacterial drug market will reach $44.13bn in 2020.

You can also see which companies hold the most potential:
- Pfizer
- Merck & Co.
- GlaxoSmithKline
- Novartis
- Bayer
- Taisho Pharmaceuticals
- AstraZeneca
- Abbott Labs
- Daiichi Sankyo

Research and development - assess innovation, trends and possibilities
Our report discusses R&D, appraising technological, clinical and commercial possibilities.
There are 19 antibacterial drugs in phase III trials. Our report discusses:
- Small Molecule Antibacterial Drugs
- Inhaled Antibacterial Drug Formulations
- Biological Antibacterial Therapeutics
- Other Classes

How the Antibacterial Drug Market report helps you
- Revenues for antibacterial drug market to 2026 – assess the overall world drugs market’s potential and receive forecasted revenues.
- Products’ sales to 2026 – discover the predicted revenues of Zyvox, Cubicin,and Augmentin, amongst other leading brands.
- National market forecasting to 2026 for 12 countries – explore the best regions for treatment demand, sales and growth
- R&D activities – see the progress, trends and prospects in that ophthalmic research and development, finding technological, clinical and commercial possibilities
- Leading companies – examine the participants, including Pfizer, Merck & Co., and GlaxoSmithKline.
- Analysis of what stimulates and restrains that industry and market – assess challenges and strengths there, helping you compete and gain advantage.
- Two interviews with stakeholders in the antibacterial drug market.

Our brand new survey, by our in-house UK-based analysts, provides knowledge to benefit your research, analyses, plans, decisions and proposals. It reveals information you will find nowhere else.

Our investigation provides you with definitive data, trends, opportunities and sales predictions to 2026 for the antibacterial drug market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Infectious Disease Drugs: The Chinese Market

Infectious Disease Drugs: The Chinese Market

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Assess market dynamics of Chinese market for both communicable and - non-communicable infectious disease drugs, their opportunities and restraints. - Evaluate Chinese drug market ...

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance Summary The antibacterial drug market covers ...

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • $ 4995
  • Industry report
  • March 2017
  • by GBI Research

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market Summary Respiratory complications are a ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in the UK

  • April 2017
    11 pages
  • Anti-Infective  

    Point Of Care T...  

    Hospital  

  • United Kingdom  

View report >

Anti-Infective Market in the US - Forecast

  • April 2017
    4 pages
  • Anti-Infective  

  • United States  

View report >

Anti-Infective Market in Australia and the US - Forecast

  • April 2017
    8 pages
  • Anti-Infective  

    Meat  

  • Australia  

    United States  

    Europe  

View report >

Related Market Segments :

Anti-Infective

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.